Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001730463-20-000011
Filing Date
2020-11-05
Accepted
2020-11-05 16:03:21
Documents
70
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 6-K autolus-20200930x6k.htm 6-K 23932
2 EX-99.1 autl-20200930.htm   iXBRL EX-99.1 1012088
3 EX-99.2 exhibit992-operatingresult.htm EX-99.2 205453
  Complete submission text file 0001730463-20-000011.txt   5278019

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT autl-20200930.xsd EX-101.SCH 39584
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT autl-20200930_cal.xml EX-101.CAL 61982
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT autl-20200930_def.xml EX-101.DEF 221220
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT autl-20200930_lab.xml EX-101.LAB 451303
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT autl-20200930_pre.xml EX-101.PRE 337191
9 EXTRACTED XBRL INSTANCE DOCUMENT autl-20200930_htm.xml XML 775752
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38547 | Film No.: 201290359
SIC: 2836 Biological Products, (No Diagnostic Substances)